Annals of Oncology
@Annals_Oncology
Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
ID:44614314
https://www.annalsofoncology.org/ 04-06-2009 13:26:20
3,9K Tweets
46,5K Followers
520 Following
In Annals of Oncology, results of translational analyses studying the predictive and prognostic values of molecular subtypes & genomic alterations 🧬 in the MITO END-3 trial investigating the addition of Avelumab to chemo in metastatic endometrial cancer
annalsofoncology.org/article/S0923-…
🚀 Just out in Annals of Oncology: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer.
Honored to be a part of it, diving into the current evidence & future directions for clinical ADC development
annalsofoncology.org/article/S0923-…
🆕 Tissue-agnostic FDA Oncology accelerated approval for anti-HER2 ADC trastuzumab deruxtecan for unresectable or metastatic HER2-positive (IHC3+) solid tumors who have received prior systemic treatment & have no satisfactory alternative treatment options
fda.gov/drugs/resource…
❓What timing for radiotherapy☢️after radical prostatectomy for prostate cancer?
Results of the RADICALS-RT randomized trial of adjuvant RT vs observation with salvage RT for PSA failure are published in Annals of Oncology
Matt Sydes @mrcctu @pcaparker
annalsofoncology.org/article/S0923-…